Cargando…
The Role of Tumour Metabolism in Cisplatin Resistance
Cisplatin is a chemotherapy drug commonly used in cancer treatment. Tumour cells are more sensitive to cisplatin than normal cells. Cisplatin exerts an antitumour effect by interfering with DNA replication and transcription processes. However, the drug-resistance properties of tumour cells often cau...
Autores principales: | Wang, Lude, Zhao, Xiaoya, Fu, Jianfei, Xu, Wenxia, Yuan, Jianlie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261055/ https://www.ncbi.nlm.nih.gov/pubmed/34250022 http://dx.doi.org/10.3389/fmolb.2021.691795 |
Ejemplares similares
-
Inhibition of MAT2A-Related Methionine Metabolism Enhances The
Efficacy of Cisplatin on Cisplatin-Resistant Cells in Lung Cancer
por: Zhao, Xiaoya, et al.
Publicado: (2022) -
Inhibition of Serine Metabolism Promotes Resistance to Cisplatin in Gastric Cancer
por: Zhao, Xiaoya, et al.
Publicado: (2020) -
ROS-Induced DCTPP1 Upregulation Contributes to Cisplatin Resistance in Ovarian Cancer
por: Wang, Yu, et al.
Publicado: (2022) -
Culprits of PDAC resistance to gemcitabine and immune checkpoint inhibitor: Tumour microenvironment components
por: Hsu, Sheng-Kai, et al.
Publicado: (2022) -
SYVN1-MTR4-MAT2A Signaling Axis Regulates Methionine Metabolism in Glioma Cells
por: Wang, Lude, et al.
Publicado: (2021)